Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Molecular 'Feedback Loop' May Explain Tamoxifen Resistance in Patients with Breast Cancer

September 25, 2015 9:48 am | by Johns Hopkins University | News | Comments

For reasons unknown, many patients with breast cancer treated with the estrogen receptor-blocking drug tamoxifen eventually become resistant to the treatment despite the fact that their cancer cells still have the estrogen receptor proteins that the drug normally targets. Read more...


Low Dose Beta-Blockers As Effective As High Dose After a Heart Attack

September 25, 2015 9:38 am | by Northwestern University | News | Comments

In a surprising new finding, heart attack patients treated with a substantially lower dosage of beta-blockers than used in earlier clinical trials showing their effectiveness survived at the same rate, or even better, than patients on the higher doses used in those trials. Read more...


Five “Scientist Artists” Paint Exciting Future for Cancer Research

September 25, 2015 9:12 am | by Cynthia Fox, Science Editor | Articles | Comments

At a recent New York Academy of Science (NYAS) panel, five leading "scientist artists” as they were called by NYAS moderator Brooke Grindlinger discussed the not-too-distant future of cancer research, painting a world where current technologies will be leveraged to the point where most cancers will be captured in the earliest pre-cancer stages, routinely at annual physicals, via a simple blood test. Read more...


Good News for Hay Fever Sufferers

September 25, 2015 8:15 am | by University of Melbourne | News | Comments

A forecast of below average rainfall over spring is expected to give hay fever sufferers in Melbourne a bit of reprieve this season. Read more...


Antidepressants Plus Blood-Thinners Slow Down Brain Cancer

September 25, 2015 8:00 am | by Ecole Polytechnique Federale De Lausanne | News | Comments

EPFL scientists have found that combining antidepressants with anticoagulants slows down brain tumors (gliomas) in mice. Read more...


Novartis Launches Portfolio of Affordable Medicines for Low-Income Countries

September 25, 2015 7:45 am | News | Comments

The portfolio addresses cardiovascular diseases, diabetes, respiratory illnesses, and breast cancer. Read more...


Researchers are Working on Vaccine for Severe Viral Brain Infection

September 25, 2015 7:30 am | by University of Zurich | News | Comments

Researchers from the University of Zurich and the University Hospital Zurich reveal possible new treatment methods for a rare, usually fatal brain disease. Read more...


Promising Drugs Turn Immune System On Cancer

September 25, 2015 7:15 am | by Cancer Research UK | News | Comments

Cancer Research UK scientists have shown that a class of experimental drug treatments already in clinical trials could also help the body’s immune system to fight cancer. Read more...


GSK Gains Positive Opinion from CHMP for Asthma Injection

September 25, 2015 7:00 am | News | Comments

This decision is based on the results from the clinical study program. Read more...


Oregon Lab Analyst Allegedly Stole Prescription Pills from Evidence Locker

September 24, 2015 11:26 am | by Sean Alloca, Editor, Forensic Magazine | News | Comments

Nika Larsen, 35, is suspected of tampering with evidence, according to reports, and has been put on administrative leave until further notice. Read more...


Purdue, AnaBios to Collaborate on Advancing Pain Pill Research

September 24, 2015 11:21 am | by Ryan Bushey, Associate Editor | News | Comments

This partnership will focus on compounds that are targeting an area called the Nav1.7 sodium ion channel. Read more...


Revolutionary Gene-editing Technique to Stop AIDS Virus in Its Tracks

September 24, 2015 11:04 am | by University of Nevada, Las Vegas | News | Comments

Researchers have engineered a new protein that they believe has placed science much closer to an HIV cure. A patent application has been filed and testing is underway on the protein—called HT-TALENs —which uses a newly developed gene-editing technique to rid the body's cells of the immunodeficiency virus before it has a chance to multiply and possibly develop into AIDS. Read more...


New Virus Identified in Blood Supply

September 24, 2015 10:46 am | by American Society for Microbiology | News | Comments

Scientists have discovered a new virus that can be transmitted through the blood supply. Currently, it is unclear whether the virus is harmful or not, but it is related to hepatitis C virus (HCV) and human pegivirus (HPgV), the latter of which was formerly known as hepatitis G virus. Read more...


Keryx Receives European Approval for Fexeric(R) for Hyperphosphatemia Treatment

September 24, 2015 10:42 am | News | Comments

Keryx Biopharmaceuticals, Inc. today announced that the European Commission has approved Fexeric(R) (ferric citrate coordination complex) for the control of elevated serum phosphorus levels, or hyperphosphatemia, in adults with chronic kidney disease (CKD), including both dialysis and pre-dialysis patients. Read more...


Can Vitamin B Supercharge Your Dreams?

September 24, 2015 10:03 am | by University of Adelaide | News | Comments

A University of Adelaide researcher is calling for participants to assist in a new national study investigating whether vitamin B can enhance dreaming. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.